Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with <i>BRCA1</i> and <i>BRCA2</i> Mutations
Joshy George(The JAX Cancer Center), David D.L. Bowtell(Peter MacCallum Cancer Centre), Anna DeFazio(Peter MacCallum Cancer Centre), Kathryn Alsop(Peter MacCallum Cancer Centre), Douglas A. Levine(Memorial Sloan Kettering Cancer Center), Gordon K. Smyth(The University of Melbourne), Dariush Etemadmoghadam(Peter MacCallum Cancer Centre), Heather Hondow(The University of Sydney), Thomas Mikeska(The University of Sydney), Gillian Mitchell(Peter MacCallum Cancer Centre), Alexander Dobrovic(Ludwig Cancer Research)
Cited by 90
Related Papers
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
|Genome biology|2014|6.7k
Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
|Nucleic Acids Research|2012|5.8k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k